Financials

  • Market Capitalization 1.83 B
  • Employee 110
  • Founded 2024
  • CEO N/A
  • Website www.inhibrx.com
  • Headquarter Delaware, United States
  • FIGI BBG01MS5Q9G3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-10.67
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2037
TSHA
Taysha Gene Therapies, Inc. - Common Stock
5.63 USD-1.23%-6.17%-4.41%+98.24%1.83 B USD
2039
IMCR
Immunocore Holdings plc - American Depositary Shares
36.31 USD-1.49%-1.28%+7.43%+8.45%1.87 B USD
2055
SNDX
Syndax Pharmaceuticals, Inc. - Common Stock
20.34 USD+1.19%+1.40%+7.00%+26.18%1.82 B USD
2056
RXRX
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.33 USD0.00%-4.03%+9.90%-29.15%1.78 B USD

新闻